Published January 1, 2017
| Version v1
Journal article
Open
A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy
Creators
- 1. Istanbul Univ, Dept Med Biol, Istanbul Fac Med, Istanbul, Turkey
- 2. Istanbul Univ, Dept Internal Med, Div Nephrol, Istanbul Fac Med, TR-34093 Istanbul, Turkey
- 3. Haseki Training & Res Hosp, Pediat Infect Dis Unit, Istanbul, Turkey
Description
Background. The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgAl) represent the most promising candidate biomarker for IgA nephropathy (IgAN). The aim of this study was to evaluate the serum levels of Gd-IgAl as a novel noninvasive biomarker for post-transplant IgAN recurrence.
Files
bib-c361b0c2-b743-4fd3-aebc-d24bc5eb4453.txt
Files
(249 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:0149f22d5f1115af2ab8724139f1bfc2
|
249 Bytes | Preview Download |